Viridian Therapeutics, Inc. (VRDN)
14.80
0.00 (0.00%)
USD |
NASDAQ |
Apr 14, 09:33
Viridian Therapeutics Cash from Investing (TTM) : -37.56M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Marker Therapeutics, Inc. | 0.00 |
| Amgen, Inc. | -1.943B |
| Boston Scientific Corp. | -2.64B |
| Plus Therapeutics, Inc. | -0.854M |
| Nutriband, Inc. | -0.0053M |